Xue K X, Ma G J, Wu J Z
Jiangsu Institute of Cancer Research, Nanjing, China.
Zhongguo Yao Li Xue Bao. 1994 Jan;15(1):87-9.
Bimolane, 1,2-bis(4-morpholinomethyl-3,5-dioxopiperazinyl) ethane, is a new antineoplastic agent synthesized first in China. The effects of bimolane on the rate of S phase cells, mitotic index, and cytokinesis in human peripheral blood lymphocytes cultured in vitro were studied by autoradiography with [3H]TdR and counting the number of mono- and multi-nucleated lymphocytes. Results showed that bimolane (5, 10, 20 micrograms.ml-1) inhibited the progression of cell cycle, so that the rate of S and M phases decreased. Bimolane inhibited cytokinesis, which formed bi- and multi-nucleated cells. The effects were concentration-dependent. Bimolane induced micronuclei in mono- and bi-nucleated lymphocytes. Our results indicate that bimolane is a cytotoxic and genotoxic agent.
丙脒腙,1,2 - 双(4 - 吗啉甲基 - 3,5 - 二氧代哌嗪基)乙烷,是中国首先合成的一种新型抗肿瘤药物。采用[³H]TdR放射自显影术并计数单核和多核淋巴细胞数量,研究了丙脒腙对体外培养的人外周血淋巴细胞S期细胞速率、有丝分裂指数和胞质分裂的影响。结果显示,丙脒腙(5、10、20微克·毫升⁻¹)抑制细胞周期进程,使S期和M期速率降低。丙脒腙抑制胞质分裂,形成双核和多核细胞。这些作用呈浓度依赖性。丙脒腙在单核和双核淋巴细胞中诱导产生微核。我们的结果表明,丙脒腙是一种细胞毒性和基因毒性药物。